FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4225287083> ?p ?o ?g. }

• W4225287083 endingPage "975" @default.
• W4225287083 startingPage "975" @default.
• W4225287083 abstract "The continuing growth of bacterial resistance makes the top challenge for the healthcare system especially in bone-infections treatment. Current estimates reveal that in 2050 the death ratio caused by bacterial infections can be higher than cancer. The aim of this study is to provide an alternative to currently available bone-infection treatments. Here we designed mesoporous hydroxyapatite nanocarriers functionalized with citrate (Ctr-mpHANCs). Amoxicillin (AMX) is used as a model drug to load in Ctr-mpHANCs, and the drug loading was more than 90% due to the porous nature of nanocarriers. Scanning electron microscopy shows the roughly spherical morphology of nanocarriers, and the DLS study showed the approximate size of 92 nm. The Brunauer-Emmett-Teller (BET) specific surface area and pore diameter was found to be about 182.35 m2/g and 4.2 nm, respectively. We noticed that almost 100% of the drug is released from the AMX loaded Ctr-mpHANCs (AMX@Ctr-mpHANCs) in a pH-dependent manner within 3 d and 5 d at pH 2.0 and 4.5, respectively. The sustained drug release behaviour was observed for 15 d at pH 7.4 and no RBCs hemolysis by AMX@Ctr-mpHANCs. The broth dilution and colony forming unit (CFU) assays were used to determine the antimicrobial potential of AMX@Ctr-mpHANCs. It was observed in both studies that AMX@Ctr-mpHANCs showed a significant reduction in the bacterial growth of S. aureus, E. coli, and P. aeruginosa as compared to Ctr-mpHANCs with no bacteria-killing. Thus, we proposed that Ctr-mpHANCs can be used as a drug carrier and a treatment option for bone infections caused by bacteria." @default.
• W4225287083 created "2022-05-05" @default.
• W4225287083 creator A5021596422 @default.
• W4225287083 creator A5024303082 @default.
• W4225287083 creator A5030742082 @default.
• W4225287083 creator A5033814709 @default.
• W4225287083 creator A5055635576 @default.
• W4225287083 creator A5064484330 @default.
• W4225287083 creator A5067106976 @default.
• W4225287083 creator A5077146717 @default.
• W4225287083 creator A5077667933 @default.
• W4225287083 creator A5079714877 @default.
• W4225287083 date "2022-04-30" @default.
• W4225287083 modified "2023-10-14" @default.
• W4225287083 title "Synthesis and Characterization of Antibiotic–Loaded Biodegradable Citrate Functionalized Mesoporous Hydroxyapatite Nanocarriers as an Alternative Treatment for Bone Infections" @default.
• W4225287083 cites W1556912674 @default.
• W4225287083 cites W1963878748 @default.
• W4225287083 cites W1972470123 @default.
• W4225287083 cites W1973795203 @default.
• W4225287083 cites W1979973356 @default.
• W4225287083 cites W1982491228 @default.
• W4225287083 cites W1984941837 @default.
• W4225287083 cites W1993316500 @default.
• W4225287083 cites W2001709514 @default.
• W4225287083 cites W2007598776 @default.
• W4225287083 cites W2018495461 @default.
• W4225287083 cites W2028776901 @default.
• W4225287083 cites W2034878796 @default.
• W4225287083 cites W2062087152 @default.
• W4225287083 cites W2064143380 @default.
• W4225287083 cites W2071614692 @default.
• W4225287083 cites W2078616336 @default.
• W4225287083 cites W2085005040 @default.
• W4225287083 cites W2086026323 @default.
• W4225287083 cites W2088333494 @default.
• W4225287083 cites W2096341513 @default.
• W4225287083 cites W2103096499 @default.
• W4225287083 cites W2115186699 @default.
• W4225287083 cites W2115439624 @default.
• W4225287083 cites W2115933619 @default.
• W4225287083 cites W2125603952 @default.
• W4225287083 cites W2159270511 @default.
• W4225287083 cites W2170340271 @default.
• W4225287083 cites W2173071129 @default.
• W4225287083 cites W2343916603 @default.
• W4225287083 cites W2527952809 @default.
• W4225287083 cites W2546556828 @default.
• W4225287083 cites W2610501391 @default.
• W4225287083 cites W2751821287 @default.
• W4225287083 cites W2751994003 @default.
• W4225287083 cites W2800171049 @default.
• W4225287083 cites W2800973211 @default.
• W4225287083 cites W2804299729 @default.
• W4225287083 cites W2806196829 @default.
• W4225287083 cites W2902209485 @default.
• W4225287083 cites W2940854372 @default.
• W4225287083 cites W2952668961 @default.
• W4225287083 cites W2966557477 @default.
• W4225287083 cites W2980110612 @default.
• W4225287083 cites W3085885928 @default.
• W4225287083 cites W3090897708 @default.
• W4225287083 cites W3176745097 @default.
• W4225287083 cites W4200024744 @default.
• W4225287083 cites W4220733784 @default.
• W4225287083 cites W4245505926 @default.
• W4225287083 cites W843007777 @default.
• W4225287083 doi "https://doi.org/10.3390/pharmaceutics14050975" @default.
• W4225287083 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/35631561" @default.
• W4225287083 hasPublicationYear "2022" @default.
• W4225287083 type Work @default.
• W4225287083 citedByCount "3" @default.
• W4225287083 countsByYear W42252870832023 @default.
• W4225287083 crossrefType "journal-article" @default.
• W4225287083 hasAuthorship W4225287083A5021596422 @default.
• W4225287083 hasAuthorship W4225287083A5024303082 @default.
• W4225287083 hasAuthorship W4225287083A5030742082 @default.
• W4225287083 hasAuthorship W4225287083A5033814709 @default.
• W4225287083 hasAuthorship W4225287083A5055635576 @default.
• W4225287083 hasAuthorship W4225287083A5064484330 @default.
• W4225287083 hasAuthorship W4225287083A5067106976 @default.
• W4225287083 hasAuthorship W4225287083A5077146717 @default.
• W4225287083 hasAuthorship W4225287083A5077667933 @default.
• W4225287083 hasAuthorship W4225287083A5079714877 @default.
• W4225287083 hasBestOaLocation W42252870831 @default.
• W4225287083 hasConcept C13965031 @default.
• W4225287083 hasConcept C161790260 @default.
• W4225287083 hasConcept C17741926 @default.
• W4225287083 hasConcept C178790620 @default.
• W4225287083 hasConcept C18150654 @default.
• W4225287083 hasConcept C185592680 @default.
• W4225287083 hasConcept C192285135 @default.
• W4225287083 hasConcept C2779708577 @default.
• W4225287083 hasConcept C2779820397 @default.
• W4225287083 hasConcept C4937899 @default.
• W4225287083 hasConcept C501593827 @default.
• W4225287083 hasConcept C523546767 @default.
• W4225287083 hasConcept C54355233 @default.
• W4225287083 hasConcept C55493867 @default.

• next